Nitroglycerin acts, in part, to reduce arterial impedance, and thus left ventricular work. The reduction in arterial impedance is largely attributable to a fall in systemic vascular resistance, but may also be due to an increased distensibility of the arterial tree. In this study, volume distensibility of forearm arteries was calculated from measurements of pulse-wave velocity before and during intravenous nitroglycerin infusion. Since a fall in blood pressure itself increases arterial distensibility, the induced blood pressure change was controlled as a variable by repeating the measurements with the subject's forearm in a plastic cylinder and repeating the measurements at a variety of altered cylinder pressures. At every studied pressure, nitroglycerin infusion increased forearm arterial distensibility, demonstrating another way in which nitroglycerin reduces left ventricular afterload. Since the pulsatile portion of cardiac work is approximately 10% of total work, the magnitude of this nitroglycerin effect on cardiac function is probably small.
THE SALUTARY EFFECTS of nitroglycerin in patients with angina pectoris are due to the widespread action of the drug as a smooth muscle vasodilator. This vasodilation operates in the systemic veins to induce pooling, in the arterioles to reduce coronary and systemic vascular resistance, and in the epicardial coronary arteries where both normal segments and those affected by atherosclerosis are dilated. We reasoned that nitroglycerin might also increase the distensibility of peripheral muscular arteries. If this were true, such an action would reduce the oscillatory component of arterial impedance and translate into reduced left ventricular afterload and left ventricular work. This action would be yet another way in which nitroglycerin reduces myocardial oxygen need and relieves the symptoms of angina pectoris.
Since nitroglycerin lowers the blood pressure, and a lowered blood pressure itself is known to increase arterial distensibility, a problem arises in demonstrating an effect on arterial distensibility by nitroglycerin independent of its hypotensive effect. In the present study, we calculated arterial distensibility from measurements of pulse-wave velocity and controlled for changes in blood pressure by repeating the pulse-wave velocity measurements at a variety of transmural arterial pressures before and during administration of nitroglycerin.
Methods
Twenty male patients, 40 to 78 years old (mean 58.5 years), were studied. Each patient had significant coronary atherosclerosis, as evidenced by at least a 50% narrowing of a major epicardial artery at coronary arteriography ( 14 patients) or electrocardiographically proven myocardial infarction (six patients). All patients had symptomatically stable angina pectoris and were receiving individually determined doses of a variety of f3-adrenergic-blocking drugs, but none was receiving calcium channel-blocking agents. Ten patients underwent pulse-wave velocity studies before and during intravenous infusions of nitroglycerin, and the remaining 10 control patients were studied before and during intravenous infusion of saline.
In each patient all nitrate therapy was discontinued at least 12 hr before the beginning of the study. In the experimental group. nitroglycerin was administered intravenously with a calibrated Harvard infusion pump. The infusate was prepared with a nitroglycerin concentration of 140 ug/ml and the infusion was started at a rate of 50 1.g/min. Cuff blood pressures were measured in the left arm with an Arteriosonde device every 2 min and the infusion rate was increased every 6 min until the systolic arterial pressure had fallen at least 10 mm Hg. This rate of infusion was then maintained throughout the remainder of the study. The average time to reach the effective infusion rate was 22.5 + 6.5 min. Mean infusion rate was 89.5 jig/min, with a range of 50 to 200 jug/min. The 10 control patients received a similar intravenous volume of normal saline for 20 min in place of nitroglycerin.
Initially, the blood pressure was measured in both arms by the standard cuff method to exclude previously undetected arterial obstruction in either arm. Pixie strain gauges, imbedded in plastic (Endevco Corporation, San Juan Capistrano, CA), were placed over the right brachial and right radial artery of each CIRCULATION patient and held in place with soft elastic bands. Each gauge was one arm of a Wheatstone Bridge, the balanced bridge outputs were amplified (model VR6, Electronics for Medicine), and the radial dilation waves of both gauges were displayed on an oscilloscope. The gauge positions were then adjusted until undistorted pulse waves were observed. These pulses were then recorded on ultraviolet sensitive paper (Honeywell Visicorder, model 1508) at a speed of 250 mm/sec. The moment of pulse arrival was arbitrarily chosen as a point on the upstroke of the brachial and radial pulse that was 10% of the maximum pulse amplitude. The time interval between these two points was measured with the use of the inscribed time lines as a reference ( figure 1 ). This inter/al was measured on 8 beats and the mean of these values was designated the pulse transmission time. With the use of the distance between the strain gauges, the pulse-wave velocity between the two arterial loci was calculated. The pulse-wave velocity (PWV) was then converted to volume distensibility (VD) with a modification of the Bramwell-Hill equation':
The frequency response of the Pixie strain gauges has been studied previously and an average 5% loss of signal amplitude at frequencies up to 20 cycles/sec has been found. These gauges have also been found to be linear from zero force to gauge fracture . 2 With the gauges in place, the supinated arm of each subject, with elbow and wrist extended, was placed in a large plastic cylinder. The cylinder was closed at the distal end and bound proximally to the upper arm with a soft rubber sleeve. The sleeve was encircled with a blood pressure cuff and the cuff was inflated, during pulse-wave recordings, to pressures just higher than those within the cylinder. This arrangement produced only slight compression by the inflated cuff on the upper arm, but minimized air leak from within the cylinder. The cylinder pressures were varied in 10 mm Hg increments from 0 to + 50 mm Hg. Satisfactory records could not be reliably obtained at cylinder pressures higher than 50 mm Hg because of pulse distortion that probably resulted from intermittent arterial collapse. Since nitroglycerin lowered the arterial blood pressure, one set of pulse-wave velocity measurements was made during drug infusion in each patient at a negative cylinder pressure of 10 mm Hg. This served to raise the transmural pressure and to match the CONTROL GROX transmural pressure before administration of nitroglycerin. Cylinder pressures, both positive and negative, were varied with an industrial vacuum cleaner and an adjustable leak and monitored with a mercury U tube. In previous studies using this technique, a full range of negative cylinder pressures was also employed.23 Pressures more negative than minus 10 mm Hg were not used in this study to shorten study duration and minimize the discomfort of the patient resulting from maintaining a constant arm position within the cylinder for long periods of time. Since the relationship between volume distensibility and transmural arterial pressures is curvilinear (see below), the differences between volume distensibility before and during infusion of nitroglycerin should be small at negative cylinder (high transmural) pressures. Altered cylinder pressures were maintained for 30 to 60 sec before pulse waves were recorded and ambient pressures were reestablished for several minutes between runs. At the conclusion of each study, the gauges were removed and a strip of adherent paper tape was placed over the forearm running between the two gauge positions. The location of the skin indentations from the metal gauge extension was marked on the tape and the tape was removed. This strip was then placed on a flat surface and the distance between the marks was measured.
Blood pressure was measured with the Arteriosonde device in the opposite arm during the recording of arterial pulses at each cylinder pressure. The transmural arterial pressure was calculated for each run by adding or subtracting the cylinder pressure from the mean arterial pressure (mean arterial pressure = diastolic pressure + pulse pressure/3). Plots were then constructed for pulse-wave velocity and calculated volume distensibility vs transmural pressure for each patient before and during infusion. The relationship between transmural pressure and volume distensibility was curvilinear (figure 2), but that between trans- mural pressure vs log volume distensibility over the range of transmural pressures in this study was linear (figures 3 and 4). Linear regression was calculated for each plot with the method of least squares, thus permitting the calculation of pulse-wave velocity, log volume distensibility, and volume distensibility at any given pressure for each patient. The entire technic for measuring pulse-wave velocity has been described in greater detail previously. 2 3 The pulse-wave velocity has been shown to predict satisfactorily the arterial distensibility measured by independent direct methods.4-7 However, calculated volume distensibility cannot distinguish between the active or static properties of arterial wall behavior. Use of the cylinder to provide variations in transmural arterial pressure requires the assumption that cylinder pressures are transmitted faithfully to the arterial wall. Previous studies testing this assumption have shown that the transmission of increased or decreased air pressure is satisfactory.8 9 Since each patient served as his own control, individual differences in blood viscosity from patient to patient should have had little effect on the results. Velocity of blood flow adds to the pulsewave velocity, but flow velocity is small when compared with the velocity of pressure pulse travel.
Data were analyzed by use of the paired t test, and Student's t test for group data.
The study was approved by the human experimentation committee of the medical center, and each patient gave informed consent.
Results
The control and experimental groups were similar with regard to age, blood pressure, heart rate, and the prevalence of diabetes and myocardial infarction. regression lines relating these two variables were also unchanged.
The infusion of saline also produced no significant change in heart rate or systolic, diastolic, or mean blood pressure (figure 5). Figure 5 also illustrates that nitroglycerin infusion significantly reduced systolic and mean blood pressure but had no effect on diastolic blood pressure or heart rate. Tables lA and lB display the volume distensibility and pulse-wave velocity data from the control and nitroglycerin groups for representative transmural pressures of 40, 60, and 90 mm Hg. At these illustrative transmural pressures, nitroglycerin significantly increased volume distensibility when patients served as their own controls or when the response to nitroglycerin was compared with that to saline. The effect of nitroglycerin on volume distensibility over the full range of transmural pressures can be seen in figure 6 , and the effects of nitroglycerin on the log volume distensibility vs transmural pressure relationship are illustrated in figure 7 . The slope of the regression line before and after nitroglycerin was not significantly different. 
Discussion
The difficulty in understanding the mechanism of nitroglycerin action in patients with angina pectoris arises from the multiplicity of demonstrated pharmacologic effects and the lack of information regarding the precise role played by each.10 Nitroglycerin produces both its peripheral vascular and secondary cardiac effects by relaxing smooth muscle through the activation of guanylate cyclase and the resultant increase formed. Elastic modulus depends both on volume dis-4[ CONTROL tensibility and vessel geometryspecifically, the ratio of wall thickness to diameter. However, these 3~~~~~x--xN1TROGLYCERINE 2 I STD ERROR measurements are difficult to obtain in vivo. Since volume distensibility can be calculated from the noninvasive measurements of pulse-wave velocity without explicit knowledge of arterial geometry, volume distensibility has been frequently used to assess arterial a % stiffness in noninvasive studies in vivo.
In the present study, the infusion of nitroglycerin reduced the mean arterial blood pressure from 90 to 85 mm Hg. Without nitroglycerin, this reduction in blood pressure alone would induce an increase in volume 7 K X distensibility of 15%. Total left ventricular work can be divided into two major parts. The first is that portion of cardiac effort .t al.,"4 using a pulsed Doppler technique with a that drives the blood steadily through the peripheral e transducer probe, have shown an increase in the resistance and is usually calculated as the product of ter of the brachial artery during the infusion of mean blood pressure and mean flow. The second is the ,lycerin. These authors also used the diastolic ventricular work that drives no blood, but is spent in n of the brachial arterial pressure curve and the tion that is due to the stiffness of the arterial tree. Total ire itself. In that study, nitroglycerin was admin-arterial impedance is frequency dependent. At zero d in a lower dose, which reduced the systolic but frequency, the impedance is due to "steady flow" and e mean or diastolic pressure. In the present inves-is equal to the systemic vascular resistance. Corren, both systolic and mean blood pressures were spondingly smaller is the input impedance from puled, with no significant change in heart rate. This sations, which represents the opposition to left venbly was due to the concomitant use of,3-adrenertricular ejection at higher frequencies. This input locking agents in our patients. Nitroglycerin, impedance is determined by several factors, including ver, increased forearm arterial distensibility at reflected waves, pulse-wave velocity, and arterial disstudied transmural pressure.
tensibility. Averaging the higher frequency impe-;erial stiffness may be characterized by two quandances yields the "characteristic impedance," which is volume distensibility and the modulus of elasdetermined largely by arterial distensibility. Pulse-(Young's modulus). Volume distensibility meawave velocity is directly related to characteristic arterithe percentage change in volume of an arterial al impedance'6 when the latter is expressed in terms of -nt resulting from a unit change in distending linear flow velocity (dyne-sec.cm-3) rather than in ire and is therefore independent of arterial diterms of the more familiar volume flow (dyne.sec. r. The elastic modulus, on the other hand, is a cm-5). Although our measurements of pulse-wave ire of the stress-strain relationship for the blood velocity can be used to calculate characteristic imwall and quantifies its behavior when it is depedance of the forearm arteries, the aortic input im- -0.
-0.
-0., -0.4'
pedance and systemic vascular resistance were not measured. Calculation of characteristic impedances of the brachial artery from our pulse-wave velocity data showed that a reduction in mean blood pressure from 90 to 85 mm Hg without nitroglycerin would reduce characteristic impedance by 5.8%, while the same reduction due to nitroglycerin lowered characteristic impedance by 21%. Larger doses of nitroglycerin might, of course, have a larger effect. Since the influence of the characteristic impedance of the brachial artery on the aortic input impedance is unknown in these patients and since the portion of the arterial tree that behaves like the forearm arteries is also unknown, any further attempt to quantify the reduction in left ventricular work by this mechanism would be largely speculative.
The only other agent that is similar to nitroglycerin whose effects on arterial stiffness have been studied is nitroprusside, and these results have been conflicting. Pepine et al.17 reported a reduction in characteristic aortic impedance during the infusion of nitroprusside in patients with cardiomyopathy and congestive heart failure. This reduction was sustained in three patients even when their blood pressures were restored to baseline levels by phenylephrine. These results could not be confirmed in the aorta by Yin et al.,"' who did, however, find a reduction of characteristic impedance in the pulmonary artery. In patients with angina pectoris but no heart failure, Gundel et al.'9 also reported no significant change in aortic input impedance during the infusion of nitroprusside. There are obvious differences between these studies and the present one. Nitroglycerin and nitroprusside may differ in their effects on arterial smooth muscle. Measurements of aortic input impedance may be more sensitive to changes in the proximal aortic wall, where there is less smooth muscle, than to changes in the more muscular peripheral arteries. Finally, there have been no studies of effects of nitroglycerin on aortic input impedance or of nitroprusside on the distensibility of peripheral arteries.
The reduced arterial stiffness demonstrated in this study resulted from brief infusions of nitroglycerin and may not be applicable to longer acting forms of nitrate therapy. However brief, any increase in arterial distensibility should reduce the pulsatile component of arterial impedance and thus reduce left ventricular work. Such an effect could conceivably occur with or even without a concomitant reduction in systemic vascular resistance. It remains uncertain, however, whether the changes in arterial distensibility are of sufficient magnitude to play a significant role in the relief of angina pectoris or in improvement in patients with congestive heart failure.
